Inhibitors of copper-containing amine oxidases
CA 2414799 A1 · Owner: Lazar, Laszlo · Inventors: Jalkanen, Markku; Fulop, Ferenc; Smith, David John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to 1,3,4-oxadiazine compounds that function as inhibitors of copper-containg amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO) including the human SSAO known , as Vascular Adhesion Protein-1 (VAP-1). These SSAO inhibitors have therapeutic utility as drugs to treat conditions and diseases including but not limited , to, a number of inflammatory conditions and diseases (in particular chronic inflammatory conditions such as chronic arthritis inflammatory bowel , diseases, and chronic skin dermatoses) diseases related to carbohydrate , metabolism and to abberations in adipocyte differentiation or function and smooth muscle cell …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 4, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 4, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 4, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.